赛伦生物：公司正在采用新型抗体技术研发广谱抗蛇毒抗体

Core Viewpoint - The company is developing a broad-spectrum anti-snake venom antibody using new antibody technology, aiming to create an innovative drug that is universal, has fewer side effects, and is more convenient for use [1] Group 1: Company Development - The company is focused on developing innovative drugs to meet clinical needs in snakebite treatment [1] - The new antibody technology is expected to complement existing anti-snake venom serum, enhancing treatment options [1] - The goal is to improve the company's long-term competitiveness in the field of snakebite diseases [1]